Oldest pages

From OncoWiki

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. 5-FU + Cisplatin‏‎ (02:17, 7 February 2012)
  2. 5-FU + Cisplatin + Docetaxel‏‎ (02:17, 7 February 2012)
  3. 5-FU + Cisplatin + RT‏‎ (02:17, 7 February 2012)
  4. 5-FU + Cisplatin + RT + Surgery‏‎ (02:17, 7 February 2012)
  5. 5-FU + Cisplatin + Vinblastine + RT + Surgery‏‎ (02:17, 7 February 2012)
  6. Adriamycin + Cisplatin‏‎ (02:17, 7 February 2012)
  7. 5-FU + LV + Bevacizumab‏‎ (02:17, 7 February 2012)
  8. AD‏‎ (02:17, 7 February 2012)
  9. Adriamycin + Cisplatin + Paclitaxel‏‎ (02:17, 7 February 2012)
  10. 5-FU + LV + Irinotecan‏‎ (02:17, 7 February 2012)
  11. ADE‏‎ (02:17, 7 February 2012)
  12. Alemtuzumab‏‎ (02:17, 7 February 2012)
  13. 5-FU + LV + Mitomycin + Dipyridamole‏‎ (02:17, 7 February 2012)
  14. ADOC‏‎ (02:17, 7 February 2012)
  15. 5-FU + LV + RT‏‎ (02:17, 7 February 2012)
  16. AI‏‎ (02:17, 7 February 2012)
  17. 5-FU + RT‏‎ (02:17, 7 February 2012)
  18. AIDA-PETHEMA Group‏‎ (02:17, 7 February 2012)
  19. 5-FU MitomycinC Radiation Therapy EORTC Regimen‏‎ (02:17, 7 February 2012)
  20. ASHAP‏‎ (02:17, 7 February 2012)
  21. 5-FU MitomycinC Radiation Therapy Wayne State Regimen‏‎ (02:17, 7 February 2012)
  22. A-C-T‏‎ (02:17, 7 February 2012)
  23. Acute Lymphoblastic Leukemia, Adult‏‎ (02:17, 7 February 2012)
  24. ABDIC‏‎ (02:17, 7 February 2012)
  25. Acute Lymphoblastic Leukemia, Pediatric‏‎ (02:17, 7 February 2012)
  26. ABVD‏‎ (02:17, 7 February 2012)
  27. 5-FU + LV‏‎ (02:17, 7 February 2012)
  28. AC‏‎ (02:17, 7 February 2012)
  29. BFM B-Cell‏‎ (02:17, 7 February 2012)
  30. Bortezomib‏‎ (02:17, 7 February 2012)
  31. Bendamustine‏‎ (02:17, 7 February 2012)
  32. Brain Tumors Adult‏‎ (02:17, 7 February 2012)
  33. Bendamustine + Rituximab‏‎ (02:17, 7 February 2012)
  34. Breast Cancer‏‎ (02:17, 7 February 2012)
  35. Alemtuzumab + Fludarabine‏‎ (02:17, 7 February 2012)
  36. Bevacizumab‏‎ (02:17, 7 February 2012)
  37. CAF‏‎ (02:17, 7 February 2012)
  38. Amrubicin‏‎ (02:17, 7 February 2012)
  39. Bevacizumab + Erlotinib‏‎ (02:17, 7 February 2012)
  40. CALGB 8811‏‎ (02:17, 7 February 2012)
  41. Anal Carcinoma‏‎ (02:17, 7 February 2012)
  42. Bevacizumab + IFN‏‎ (02:17, 7 February 2012)
  43. Arsenic Trioxide for APML, new cases‏‎ (02:17, 7 February 2012)
  44. BiRD‏‎ (02:17, 7 February 2012)
  45. Arsenic Trioxide for relapsed APML‏‎ (02:17, 7 February 2012)
  46. Bicalutamide‏‎ (02:17, 7 February 2012)
  47. Azacitidine‏‎ (02:17, 7 February 2012)
  48. Bile Duct Cancer Extrahepatic‏‎ (02:17, 7 February 2012)
  49. BEP‏‎ (02:17, 7 February 2012)
  50. Bladder Cancer‏‎ (02:17, 7 February 2012)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)